about
Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis.Migraine associated with gastrointestinal disorders: review of the literature and clinical implications.Analgesic Effect of Electroacupuncture in a Mouse Fibromyalgia Model: Roles of TRPV1, TRPV4, and pERK.Role of 5-HT(1) receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn.A Neurologist's Guide to Acute Migraine Therapy in the Emergency Room.Treatment of perimenstrual migraine with triptans: an update.Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.Targeting CGRP: A New Era for Migraine Treatment.Triptans and migraine: advances in use, administration, formulation, and development.A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines.Advances in drug development for acute migraine.The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study.The effects of the multispecies probiotic mixture Ecologic®Barrier on migraine: results of an open-label pilot study.Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.Overview of migraine treatment.Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.Combined preconditioning with hypoxia and GYKI-52466 protects rats from cerebral ischemic injury by HIF-1α/eNOS pathway.The PPI network analysis of mRNA expression profile of uterus from primary dysmenorrheal rats.
P2860
Q34094599-36BB1704-4589-4DA4-872C-48FA619EE186Q34554827-AF5CC6BC-CB2F-4893-B125-A2C225B28E21Q35652836-18175842-9A5E-4B5D-AA61-9A5B94972A8DQ36025414-12024D2F-3327-471A-8243-3BF302F20BEAQ37080223-F7C3EF63-EAC6-4A22-909F-845BA3FB4878Q38014363-56D918DB-1302-4D0E-8088-6B461C7B73A9Q38066258-813C0132-24C1-4D04-966E-DB14FE8418FFQ38136256-F4D7CBA2-88B7-4303-9F74-4AD7054A904EQ38175067-B3D83690-D781-48CC-BA1A-FEA352A1E83CQ38542176-B272BA9D-5A86-47D6-960A-0270B8E8910CQ38994955-558A6A4A-86AF-4683-9BC0-6D157CE9D1AEQ39264893-5F8A6846-544E-41BC-9913-754A3C638191Q39340622-F3C9D14E-DBC3-4601-ACD5-2BF7276F8FADQ39527265-9D1C4099-EA32-4660-8A86-FC20EC7C6B45Q40188307-039B2D3A-FD62-44FC-926D-692E8E222547Q43456424-BF432590-99CA-4C33-A340-AFA0316BDA71Q44515056-B9B4BA0C-BEAD-4AFC-9029-87D32B92F8C3Q46098987-4F5CA43D-B683-4B49-B026-8BE853CD569BQ46550880-E369FEC6-26E0-4E21-A7B0-34FD07F2A0F4Q47294976-CE5DB125-0A9F-4A17-8A31-1B2FC2FB28D3Q49292264-8E4CD215-4AF6-4EB2-AF20-15B7ECC6B000
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Acute migraine therapy: new drugs and new approaches.
@en
type
label
Acute migraine therapy: new drugs and new approaches.
@en
prefLabel
Acute migraine therapy: new drugs and new approaches.
@en
P2860
P1476
Acute migraine therapy: new drugs and new approaches.
@en
P2093
Peter J Goadsby
Teshamae S Monteith
P2860
P2888
P356
10.1007/S11940-010-0105-6
P577
2011-02-01T00:00:00Z
P5875
P6179
1018397280